Lifecore Biomedical Inc (LFCR)
NASDAQ
Year End May 25 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | 3.017 | 6.506 | 0.089 | -7.203 | -6.256 | -24.416 | -36.29 | 4.734 |
Return on Equity (%) | 4.808 | 10.33 | 0.157 | -15.24 | -15.059 | -62.711 | -191.993 | 339.111 |
Return on Invested Capital (%) | 7.239 | 7.394 | 3.348 | -4.933 | -3.041 | -4.306 | -12.12 | -5.224 |
Operating Margin (%) | 3.164 | 3.5 | 1.591 | -7.064 | -4.617 | -18.709 | -44.814 | 21.522 |
Net Profit Margin (%) | 1.99 | 4.736 | 0.074 | -6.469 | -6.003 | -52.443 | -96.411 | 9.366 |
Book Value Per Share | 5.412 | 6.288 | 5.035 | 4.182 | 3.28 | 2.632 | 0.555 | 1.16 |
Earnings Per Share | 0.381 | 0.886 | 0.014 | -1.293 | -1.102 | -3.266 | -3.249 | 0.389 |
Cash Per Share | 0.194 | 0.103 | 0.037 | 0.012 | 0.044 | 0.055 | 0.623 | 0.274 |
Working Capital Per Share | 1.072 | 0.31 | -0.138 | -0.246 | 1.566 | 1.491 | 1.781 | 1.366 |
Operating Profit Per Share | 3.367 | 3.223 | 3.271 | 3.176 | 3.417 | 2.064 | 1.377 | 1.631 |
EBIT Per Share | 0.54 | 0.585 | 0.124 | -1.737 | -1.365 | -1.747 | -2.086 | 0.308 |
EBITDA Per Share | 0.54 | 0.585 | 0.124 | -1.737 | -1.365 | -1.747 | -2.086 | 0.308 |
Free Cash Flow Per Share | 0.816 | 1.658 | 1.017 | -1.027 | -0.97 | -2.698 | -2.901 | 0.694 |
Year End May 25 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 27.5M | 27.7M | 29.1M | 29.22M | 29.33M | 29.51M | N/A | N/A |
Year End May 25 2024 | Nov 2022 | Feb 2023 | May 2023 | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 30.3M | N/A | N/A | 30.46M | 30.46M | 30.55M | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | -35.005 | N/A | N/A | N/A | -44.068 |
Net Profit Margin (%) | N/A | N/A | N/A | -43.854 | N/A | N/A | N/A | -65.695 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 214.43M |
Price to Earnings Ratio | 18.18 |
Price to Sales Ratio | 1.7 |
Price to Cash Ratio | 25.81 |
Price to Book Ratio | 4.05 |
Dividend Yield | - |
Shares Outstanding | 30.9M |
Average Volume (1 week) | 169.64k |
Average Volume (1 Month) | 190.2k |
52 Week Change | 17.64% |
52 Week High | 8.90 |
52 Week Low | 3.6793 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.